Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.

dc.contributor.authorPuig i Sardà, Susana
dc.contributor.authorSampogna, Francesca
dc.contributor.authorTejera Vaquerizo, Antonio
dc.date.accessioned2017-05-03T17:32:43Z
dc.date.available2017-10-31T23:01:39Z
dc.date.issued2016-10
dc.date.updated2017-05-03T17:32:43Z
dc.description.abstractComentari a l'editor
dc.format.extent2 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec668018
dc.identifier.issn2168-6068
dc.identifier.pmid27732728
dc.identifier.urihttps://hdl.handle.net/2445/110405
dc.language.isoeng
dc.publisherAmerican Medical Association
dc.relation.ispartofJAMA Dermatology, 2016, vol. 152, num. 10, p. 1172-1173
dc.rights(c) American Medical Association, 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationOncologia
dc.subject.classificationTumors
dc.subject.classificationMetabolisme basal
dc.subject.otherOncology
dc.subject.otherTumors
dc.subject.otherBasal metabolism
dc.titleStudy on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
668018.pdf
Mida:
68.48 KB
Format:
Adobe Portable Document Format